This antibody against CD45 (Leukocyte Common Antigen) recognizes the 200 kD antigen found on lymphoid cells, macrophages, histiocytes, and neutrophils. CD45 is helpful in determining the leukocytic nature of anaplastic tumors. Combined with other antibodies such as those to cytokeratins and S-100 protein, this monoclonal antibody to leukocyte common antigen can be used in the characterization of undifferentiated large cell neoplasms. Most neoplastic B cells and T cells stain positive in leukemia and in non-Hodgkin’s lymphomas, whereas most neoplastic myeloid and erythroid cells are negative.
PD7/26/16 & 2B11
|Tissue Type/Cancer Type||
6 mL – Manual – RTU, 100 Tests – Automation – i6000, 1 mL – Manual – Concentrate, 0.5 mL – Manual – Concentrate, 50 Tests – Automation – Xmatrx, 50 tests – NanoVIP®, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual